EFTR (EFTR) Stock Price & Analysis
EFTR (EFTR) rose 0.00% to USD 0 as of September 8, 2026 at 15:32 UTC, according to Nexqual real-time market data.
EFTR last closed at USD 0; the session ranged USD 0–0 on volume of 331 shares. Market capitalization is —, with a 52-week range of USD 0–0.01 (PNK). Source: Nexqual, September 8, 2026 at 15:32 UTC.
Key Statistics (as of September 8, 2026 at 15:32 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0.01 |
| Volume | 331 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (EFTR)
Nexqual's technical model rates EFTR "BUY" based on 5 bullish and 1 bearish signals across 127 daily candles, as of September 8, 2026 at 15:32 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 66.52 (neutral) |
| vs SMA50 | Above (USD 0) |
| MACD | 0 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| INDP | Indaptus Therapeutics, Inc. | USD 1.68 | ▲ 44.4% |
| BTTX | Better Therapeutics, Inc. | USD 0 | ▲ 0% |
| JSPR | Jasper Therapeutics, Inc. | USD 0.72 | ▲ 5.34% |
| VRPX | Virpax Pharmaceuticals, Inc. | USD 0 | ▲ 0% |
| ABVC | ABVC Biopharma, Inc. | USD 1.07 | ▲ 7% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 15:32 UTC. This page is informational and not investment advice.